Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


AstraZeneca reported $8.33B in Operating Expenses for its fiscal quarter ending in March of 2023.

Operating Expenses Change
AbbVie ABBV:US USD 9.46B 162M
Alcon AG ALC:SW USD 2.08B 66M
Almirall SA ALM:SM EUR 427.56M 38.74M
Amgen AMGN:US USD 4.07B 538M
Artemis Alpha ATS:LN GBP 748K 85K
AstraZeneca AZN:LN USD 8.33B 1.78B
Bayer BAYN:GR EUR 11.42B 848M
Biogen BIIB:US USD 1.96B 111.2M
Bristol-Myers Squibb BMY:US USD 8.24B 1.22B
Eli Lilly LLY:US USD 5.47B 600K
Fresenius FRE:GR EUR 9.44B 518M
Fresenius Medical Care FME:GR EUR 4.44B 201.87M
Galapagos GLPG:NA EUR 165.2M 79.76M
Genmab GEN:DC DKK 2.42B 145M
Gilead Sciences GILD:US USD 4.65B 475M
GlaxoSmithKline GSK:LN GBP 4.87B 640M
Hikma Pharmaceutical HIK:LN USD 1.24B 280M
Lonza Group LONN:SW CHF 2.35B 8M
Merck & Co MRK:US USD 10.76B 371M
Novartis NOVN:VX USD 10.35B 700M
Orion ORNBV:FH EUR 222.4M 31.4M
Pfizer PFE:US USD 11.5B 7.63B
Philips PHIA:NA EUR 4.75B 501M
Recordati REC:IM EUR 377.95M 6.27M
Regeneron Pharmaceuticals REGN:US USD 2.22B 52.2M
Roche Holding ROG:VX 25.06B 4.31B